Table 2 Statin adherence during the initial 12-month follow-up period of the all new statin users, primary and secondary prevention subgroups
All new statin users N = 109,306 | Primary prevention subgroup N = 34,372 | Secondary prevention subgroup N = 65,283 | |
|---|---|---|---|
PDC, mean (SD) | 0.20 (0.16) | 0.19 (0.15) | 0.19 (0.16) |
Subgroups with 0.2 as interval, n (%) | |||
0 ≤ PDC < 0.2 | 71,580 (65.5) | 22,899 (66.6) | 43,323 (66.4) |
0.2 ≤ PDC < 0.4 | 25,652 (23.5) | 7879 (22.9) | 15,273 (23.4) |
0.4 ≤ PDC < 0.6 | 8510 (7.8) | 2637 (7.7) | 4753 (7.3) |
0.6 ≤ PDC < 0.8 | 2701 (2.5) | 769 (2.2) | 1437 (2.2) |
0.8 ≤ PDC ≤ 1.0 | 865 (0.8) | 188 (0.6) | 497 (0.8) |
Subgroups with 0.5 as interval, n (%) | |||
0 ≤ PDC < 0.5 | 102,820 (94.1) | 32,507 (94.6) | 61,768 (94.6) |
0.5 ≤ PDC ≤ 1.0 | 6486 (5.9) | 1865 (5.4) | 3515 (5.4) |